Skip to content

Occurrence of laryngospasm in pediatric patients

Comparison of the incidence of laryngospasm after removal of the laryngeal mask airway (LMA) using two methods coated with lidocaine gel and coated with plain lubricant in pediatric patients presenting to the hospital

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250116064403N1
Enrollment
60
Registered
2026-05-06
Start date
2026-06-22
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laryngospasm. Laryngeal spasm

Interventions

Intervention 1: Intervention group:. In the intervention group, LMA insertion will be performed using lidocaine gel (Xylogel 2%, Sinadaroo, Iran). Intervention 2: Control group: In the control group,

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) Physical Status Classification System: Class 1 Candidates undergoing surgery with Laryngeal Mask Airway (LMA) insertion Parental consent for participation in the study Pediatric weight between 5 to 20 kg

Exclusion criteria

Exclusion criteria: The duration of the surgery more than 2 hours Bleeding that leads to blood transfusion during surgery Surgical complication leading to severe hemodynamic instability of the patient during surgery Airway problems such as obstruction

Design outcomes

Primary

MeasureTime frame
Laryngospasm. Timepoint: During extubation of the laryngeal airway mask. Method of measurement: standardized laryngospasm grading scale.;Cough. Timepoint: After transferring the patient to recovery and 12 hours after the end of surgery. Method of measurement: Cough Severity Grading Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Mahdavi

Shahid Beheshti University of Medical Sciences

alirezamahdavi@sbmu.ac.ir+98 21 2222 7029

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026